Department of Immunobiology, Yale University School of Medicine, New Haven, CT, 06520, USA.
Department Cell Biology, Yale University School of Medicine, New Haven, CT, 06520, USA.
Immunogenetics. 2019 Mar;71(3):141-160. doi: 10.1007/s00251-018-01098-2. Epub 2019 Jan 29.
My intention here is to describe the history of the molecular aspects of the antigen processing field from a personal perspective, beginning with the early identification of the species that we now know as MHC class I and MHC class II molecules, to the recognition that their stable surface expression and detection by T cells depends on peptide association, and to the unraveling of the biochemical and cell biological mechanisms that regulate peptide binding. One goal is to highlight the role that serendipity or, more colloquially, pure blind luck can play in advancing the research enterprise when it is combined with an appropriately receptive mind. This is not intended to be an overarching review, and because of my own work I focus primarily on studies of the human MHC. This means that I neglect the work of many other individuals who made advances in other species, particularly those who produced the many knockout mouse strains used to demonstrate the importance of the antigen processing machinery for initiating immune responses. I apologize in advance to colleagues around the globe whose contributions I deal with inadequately for these reasons, and to those whose foundational work is now firmly established in text books and therefore not cited. So many individuals have worked to advance the field that giving all of them the credit they deserve is almost impossible. I have attempted, while focusing on work from my own laboratory, to point out contemporaneous or sometimes earlier advances made by others. Much of the success of my own laboratory came because we simultaneously worked on both the MHC class I and class II systems and used the findings in one area to inform the other, but mainly it depended on the extraordinary group of students and fellows who have worked on these projects over the years. To those who worked in other areas who are not mentioned here, rest assured that I appreciate your efforts just as much.
我的目的是从个人角度描述抗原加工领域分子方面的历史,从早期鉴定我们现在所知的 MHC I 类和 MHC II 类分子的物种开始,到认识到它们的稳定表面表达和被 T 细胞检测依赖于肽的结合,再到阐明调节肽结合的生化和细胞生物学机制。其目的之一是强调在研究事业中,当偶然或更通俗地说,纯粹的盲目运气与适当的接受心态相结合时,可能会发挥作用。这并不是一个全面的综述,由于我自己的工作,我主要集中在人类 MHC 的研究上。这意味着我忽略了许多在其他物种中取得进展的其他人的工作,特别是那些产生了许多用于证明抗原加工机制对启动免疫反应重要性的敲除小鼠品系的人。由于这些原因,我预先向全球的同事道歉,他们的贡献我没有充分处理,对于那些基础工作现在已经牢固确立在教科书中的人,我也没有引用。有太多的人致力于推进这一领域,几乎不可能把所有的功劳都归功于他们。在专注于自己实验室的工作的同时,我试图指出同时期或有时更早的其他人的进展。我自己的实验室之所以取得很大的成功,是因为我们同时研究了 MHC I 类和 II 类系统,并将一个领域的发现应用于另一个领域,但主要还是依赖于多年来在这些项目上工作的那群杰出的学生和研究员。对于这里没有提到的在其他领域工作的人,请放心,我同样感谢你们的努力。